The human gut microbiome - A potential controller of wellness and disease

Frontiers in Microbiology

Volumn 9, Issue AUG, 2018, Pages

  Kho, Zhi Y ^a   Lal, Sunil K ^a  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Autism; Celiac disease; Clostridium difficile infection; Colorectal cancer; Dysbiosis; Inflammatory bowel disease; Microbiome; Obesity

Indexed keywords

ACETYLCHOLINE; BLOOD CLOTTING FACTOR 13; CD14 ANTIGEN; CYANOCOBALAMIN; ENTEROTOXIN; G PROTEIN COUPLED BILE ACID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 41; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MEMBRANE PROTEIN; PANTOTHENIC ACID; PROTEIN BCL 2; PROTEIN ZO1; RNA 16S; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VASCULOTROPIN;

AUTISM; CELIAC DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COLORECTAL CANCER; DYSBIOSIS; HUMAN; IMMUNITY; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; METABOLISM; METABOLITE; NERVOUS SYSTEM; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW;

EID: 85051459505     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.01835     Document Type: Review

References (219)

1. Abed, J., Emgård, J. E., Zamir, G., Faroja, M., Almogy, G., Grenov, A., et al. (2016). Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20, 215-225. doi: 10.1016/j.chom.2016.07.006
2. Abrahamse, S. L., Pool-Zobel, B. L., and Rechkemmer, G. (1999). Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis 20, 629-634. doi: 10.1093/carcin/20.4.629
3. Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., and Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11:22. doi: 10.1186/1471-230x-11-22
4. Ajouz, H., Mukherji, D., and Shamseddine, A. (2014). Secondary bile acids: an underrecognized cause of colon cancer. World J. Surg. Oncol. 12:164. doi: 10.1186/1477-7819-12-164
5. Akobeng, A. K., Ramanan, A. V., Buchan, I., and Heller, R. F. (2006). Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch. Dis. Child. 91, 39-43. doi: 10.1136/adc.2005.082016
6. Andres, E., Loukili, N. H., Noel, E., Kaltenbach, G., Abdelgheni, M. B., Perrin, A. E., et al. (2004). Vitamin B12 (cobalamin) deficiency in elderly patients. Can. Med. Assoc. J. 171, 251-259. doi: 10.1503/cmaj.1031155
7. Anitha, M., Vijay-Kumar, M., Sitaraman, S. V., Gewirtz, A. T., and Srinivasan, S. (2012). Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 143, 1006-1016. doi: 10.1053/j.gastro.2012.06.034
8. Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., and Young, V. B. (2009). Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77, 2367-2375. doi: 10.1128/iai.01520-08
9. Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683-691. doi: 10.1136/gutjnl-2015-310912
10. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., et al. (2008). ATP drives lamina propria TH17 cell differentiation. Nature 455, 808-812. doi: 10.1038/nature07240
11. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
12. Barnaba, V., and Sinigaglia, F. (1997). Molecular mimicry and T cell-mediated autoimmune disease. J. Exp. Med. 185, 1529-1532. doi: 10.1084/jem.185.9.1529
13. Bartlett, J. G. (1982). Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea or colitis. Obstet. Gynecol. Surv. 37:46. doi: 10.1097/00006254-198201000-00019
14. Bartlett, J. G. (2002). Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346, 334-339. doi: 10.1056/NEJMcp011603
15. Bendheim, P. E., Poeggeler, B., Neria, E., Ziv, V., Pappolla, M. A., and Chain, D. G. (2002). Development of indole-3-propionic acid (OXIGON™) for Alzheimer's disease. J. Mol. Neurosci. 19, 213-217. doi: 10.1007/s12031-002-0036-0
16. Blottière, H. M., Buecher, B., Galmiche, J. P., and Cherbut, C. (2003). Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc. Nutr. Soc. 62, 101-106. doi: 10.1079/PNS2002215
17. Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J. P., et al. (2006). A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754-759. doi: 10.1016/j.cgh.2006.03.028
18. Britton, R. A., and Young, V. B. (2012). Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20, 313-319. doi: 10.1016/j.tim.2012.04.001
19. Campbell, D. B., Buie, T. M., Winter, H., Bauman, M., Sutcliffe, J. S., Perrin, J. M., et al. (2009). Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 123, 1018-1024. doi: 10.1542/peds.2008-0819
20. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes Metab. Res. Rev 56, 1761-1772. doi: 10.2337/db06-1491
21. Carr, E. G., and Owen-Deschryver, J. S. (2007). Physical illness, pain, and problem behavior in minimally verbal people with developmental disabilities. J. Autism. Dev. Disord. 37, 413-424. doi: 10.1007/s10803-006-0176-0
22. Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., et al. (2012). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306. doi: 10.1101/gr.126516.111
23. Chen, T., Kim, C. Y., Kaur, A., Lamothe, L., Shaikh, M., Keshavarzian, A., et al. (2017). Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. Food Funct. 8, 1166-1173. doi: 10.1039/c6fo01532h
24. Cherrington, C. A., Hinton, M., Pearson, G. R., and Chopra, I. (1991). Short-chain organic acids at pH 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J. Appl. Microbiol. 70, 161-165
25. Christensen, D. L., Baio, J., Braun, K. V., Bilder, D., Charles, J., Constantino, J. N., et al. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill. Summ. 65, 1-23. doi: 10.15585/mmwr.ss6503a1
26. Christensen, K. R., Steenholdt, C., Buhl, S. S., Ainsworth, M. A., Thomsen, O. Ø, and Brynskov, J. (2015). Systematic information to health-care professionals about vaccination guidelines improves adherence in patients with inflammatory bowel disease in anti-tnfa therapy. Am. J. Gastroenterol. 110, 1526-1532. doi: 10.1038/ajg.2015.162
27. Cianchi, F., Cortesini, C., Fantappiè, O., Messerini, L., Schiavone, N., Vannacci, A., et al. (2003). Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am. J. Pathol. 162, 793-801. doi: 10.1016/S0002-9440(10)63876-X
28. Collins, J., Borojevic, R., Verdu, E. F., Huizinga, J. D., and Ratcliffe, E. M. (2014). Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterol. Motil. 26, 98-107. doi: 10.1111/nmo.12236
29. Constantino, J. N., Przybeck, T., Friesen, D., and Todd, R. D. (2000). Reciprocal social behavior in children with and without pervasive developmental disorders. J. Dev. Behav. Pediatr. 21, 2-11. doi: 10.1097/00004703-200002000-00002
30. Cooke, G., Behan, J., and Costello, M. (2006). Newly identified vitamin K-producing bacteria isolated from the neonatal faecal flora. Microb. Ecol. Health Dis. 18, 133-138. doi: 10.3402/mehd.v18i3-4.7681
31. Croft, A., Walsh, A., Doecke, J., Cooley, R., Howlett, M., and Radford-Smith, G. (2013). Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: cyclosporine vs. Infliximab. Aliment. Pharmacol. Ther. 38, 294-302. doi: 10.1111/apt.12375
32. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Martino, P. D., Desreumaux, P., et al. (1998). Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohns disease. Gastroenterol. 115, 1405-1413. doi: 10.1016/s0016-5085(98)70019-8
33. D'arienzo, R., Stefanile, R., Maurano, F., Mazzarella, G., Ricca, E., Troncone, R., et al. (2011). Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand. J. Immunol. 74, 335-341. doi: 10.1111/j.1365-3083.2011.02582.x
34. De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., et al. (2010). Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10:63. doi: 10.1186/1471-2180-10-63
35. De Preter, V., Joossens, M., Ballet, V., Shkedy, Z., Rutgeerts, P., Vermeire, S., et al. (2013). Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin. Transl. Gastroenterol. 4:e30. doi: 10.1038/ctg.2012.24
36. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., et al. (2014). Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96. doi: 10.1016/j.cell.2013.12.016
37. Degnan, P. H., Taga, M. E., and Goodman, A. L. (2014). Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 20, 769-778. doi: 10.1016/j.cmet.2014.10.002
38. Deguchi, T., Ohtsuki, S., Otagiri, M., Takanaga, H., Asaba, H., Mori, S., et al. (2002). Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int. 61, 1760-1768. doi: 10.1046/j.1523-1755.2002.00318.x
39. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J., and Dinan, T. (2010). Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170, 1179-1188. doi: 10.1016/j.neuroscience.2010.08.005
40. Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Holle, A. V., Muccioli, G. G., et al. (2011). Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J. Nutr. Biochem. 22, 712-722. doi: 10.1016/j.jnutbio.2010.05.009
41. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351. doi: 10.1172/jci200523621
42. Donohoe, D. R., Garge, N., Zhang, X., Sun, W., Oconnell, T. M., Bunger, M. K., et al. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517-526. doi: 10.1016/j.cmet.2011.02.018
43. Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M., et al. (2006). Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. 41, 408-419. doi: 10.1080/00365520500235334
44. Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., etal. (2012). Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 513-520 doi: 10.1111/j.1365-2982.2012.01893.x
45. Duchmann, R., May, E., Heike, M., Knolle, P., Neurath, M., and zum Bschenfelde, K. M. (1999). T cell specificity and cross reactivity towards Enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44, 812-818. doi: 10.1136/gut.44.6.812
46. Dumas, M. E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., et al. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 103, 12511-12516. doi: 10.1073/pnas.0601056103
47. Ebert, M. N., Klinder, A., Peters, W. H., Schäferhenrich, A., Sendt, W., Scheele, J., et al. (2003). Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24, 1637-1644. doi: 10.1093/carcin/bgg122
48. El Aidy, S., van Baarlen, P., Derrien, M., Lindenbergh-Kortleve, D. J., Hooiveld, G., Levenez, F., et al. (2012). Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol. 5, 567-579. doi: 10.1038/mi.2012.32
49. Erny, D., de Angelis, A. L. H., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965-977. doi: 10.1038/nn.4030
50. Faith, J. J., Rey, F. E., O'donnell, D., Karlsson, M., McNulty, N. P., Kallstrom, G., et al. (2010). Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 4, 1094-1098. doi: 10.1038/ismej.2010.110
51. Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J. F., Sandborn, W. J., et al. (2013). Vedolizumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 369, 699-710. doi: 10.1056/NEJMoa1215734
52. Femia, A. P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., et al. (2002). Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953-1960. doi: 10.1093/carcin/23.11.1953
53. Fernandez, F., and Collins, M. D. (1987). Vitamin K composition of anaerobic gut bacteria. FEMS Microbiol. Lett. 41, 175-180. doi: 10.1016/0378-1097(87)90233-3
54. Firmansyah, A., Penn, D., and Lebenthal, E. (1989). Isolated colonocyte metabolism of glucose, glutamine, n-butyrate, and β-hydroxybutyrate in malnutrition. Gastroenterology 97, 622-629. doi: 10.1016/0016-5085(89)90633-1
55. Forster, V. J., McDonnell, A., Theobald, R., and McKay, J. A. (2017). Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity. Epigenomics 9, 1205-1218. doi: 10.2217/epi-2016-0165
56. Franceschi, S., Panza, E., Vecchia, C. L., Parazzini, F., Decarli, A., and Porro, G. B. (1987). Nonspecific inflammatory bowel disease and smoking. Am. J. Epidemiol. 125, 445-452. doi: 10.1093/oxfordjournals.aje.a114550
57. Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H., van der Meer, I. M., et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the rotterdam study. J. Nutr. 134, 3100-3105. doi: 10.1093/jn/134.11.3100
58. Gent, A., Hellier, M., Grace, R., Swarbrick, E., and Coggon, D. (1994). Inflammatory bowel disease and domestic hygiene in infancy. Lancet 343, 766-767. doi: 10.1016/s0140-6736(94)91841-4
59. Genth, H., Huelsenbeck, J., Hartmann, B., Hofmann, F., Just, I., and Gerhard, R. (2006). Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett. 580, 3565-3569. doi: 10.1016/j.febslet.2006.04.100
60. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., et al. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359. doi: 10.1126/science.1124234
61. Goldin, B. R., Gualtieri, L. J., and Moore, R. P. (1996). The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr. Cancer 25, 197-204. doi: 10.1080/01635589609514442
62. Gominak, S. (2016). Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a 'pro-inflammatory' state associated with atherosclerosis and autoimmunity. Med. Hypotheses 94, 103-107. doi: 10.1016/j.mehy.2016.07.007
63. Gopal-Srivastava, R., and Hylemon, P. B. (1988). Purification and characterization of bile salt hydrolase from Clostridium perfringens. J. Lipid Res. 29, 1079-1085
64. Górski, A., Midzybrodzki, R., Weber-Dabrowska, B., Fortuna, W., Letkiewicz, S., Rogóz, P., et al. (2016). Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front. Microbiol. 7:1515. doi: 10.3389/fmicb.2016.01515
65. Griffiths, E. A., Duffy, L. C., Schanbacher, F. L., Qiao, H., Dryja, D., Leavens, A., et al. (2004). In vivo effects of Bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in balb/c mice. Dig. Dis. Sci. 49, 579-589. doi: 10.1023/b:ddas.0000026302.92898.ae
66. Grishin, A. M., Beyrakhova, K. A., and Cygler, M. (2015). Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host. Protein Sci. 24, 604-620. doi: 10.1002/pro.2636
67. Gronbach, K., Flade, I., Holst, O., Lindner, B., Ruscheweyh, H. J., Wittmann, A., et al. (2014). Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction in mice. Gastroenterology 146, 765-775. doi: 10.1053/j.gastro.2013.11.033
68. Guo, X., Rao, J. N., Liu, L., Zou, T., Keledjian, K. M., Boneva, D., et al. (2005). Polyamines are necessary for synthesis and stability of occludin protein in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1159-G1169. doi: 10.1152/ajpgi.00407.2004
69. Guo, X., Rao, J. N., Liu, L., Zou, T. T., Turner, D. J., Bass, B. L., et al. (2003). Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am. J. Physiol. Cell Physiol. 285, C1174-C1187. doi: 10.1152/ajpcell.00015.2003
70. Hassig, C. A., Tong, J. K., and Schreiber, S. L. (1997). Fiber-derived butyrate and the prevention of colon cancer. Chem. Biol. 4, 783-789. doi: 10.1016/S1074-5521(97)90111-3
71. Higuchi, N., Kato, M., Shundo, Y., Tajiri, H., Tanaka, M., Yamashita, N., et al. (2008). Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol. Res. 38, 1122-1129. doi: 10.1111/j.1872-034x.2008.00382.x
72. Hooper, L. V., and Gordon, J. I. (2001). Commensal host-bacterial relationships in the gut. Science 292, 1115-1118. doi: 10.1126/science.1058709
73. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603. doi: 10.1038/35079107
74. Hyde, G. M., Thillainayagam, A. V., and Jewell, D. P. (1998). Intravenous cyclosporin as rescue therapy in severe ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 10, 411-414. doi: 10.1097/00042737-199805000-00010
75. Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., and Dent, P. (2009). Bile acids as regulatory molecules. J. Lipid Res. 50, 1509-1520. doi: 10.1194/jlr. R900007-JLR200
76. Ieraci, A., Forni, P. E., and Ponzetto, C. (2002). Viable hypomorphic signaling mutant of the met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc. Natl. Acad. Sci. U.S.A. 99, 15200-15205. doi: 10.1073/pnas.222362099
77. Inagaki, T., Moschetta, A., Lee, Y. K., Peng, L., Zhao, G., Downes, M., et al. (2006). Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 3920-3925. doi: 10.1073/pnas.0509592103
78. Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., et al. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498. doi: 10.1016/j.cell.2009.09.033
79. Jackson, P. B., Boccuto, L., Skinner, C., Collins, J. S., Neri, G., Gurrieri, F., et al. (2009). Further evidence that the rs1858830 C variant in the promoter region of theMETgene is associated with autistic disorder. Autism Res. 2, 232-236. doi: 10.1002/aur.87
80. Johanesen, P. A., Mackin, K. E., Hutton, M. L., Awad, M. M., Larcombe, S., Amy, J. M., et al. (2015). Disruption of the gut microbiome: Clostridium difficile infection and the threat of antibiotic resistance. Genes 6, 1347-1360. doi: 10.3390/genes6041347
81. Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G. C. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U.S.A. 105, 15064-15069. doi: 10.1073/pnas.0803124105
82. Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., et al. (2015). Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21, 891-897. doi: 10.1016/j.cmet.2015.04.011
83. Joossens, M., De Preter, V., Ballet, V., Verbeke, K., Rutgeerts, P., and Vermeire, S. (2012). Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut 61:958. doi: 10.1136/gutjnl-2011-300413
84. Kabouridis, P. S., Lasrado, R., McCallum, S., Chng, S. H., Snippert, H. J., Clevers, H., et al. (2015). Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85, 289-295. doi: 10.1016/j.neuron.2014.12.037
85. Kalliomäki, M., Kirjavainen, P., Eerola, E., Kero, P., Salminen, S., and Isolauri, E. (2001). Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107, 129-134. doi: 10.1067/mai.2001.111237
86. Kamada, N., Chen, G. Y., Inohara, N., and Núñez, G. (2013). Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690. doi: 10.1038/ni.2608
87. Kawashima, H., Nakajima, Y., Matubara, Y., Nakanowatari, J., Fukuta, T., Mizuno, S., et al. (1997). Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in hypercholesterolemic rabbits. Jpn. J. Pharmacol. 75, 135-143. doi: 10.1254/jjp.75.135
88. Kelly, J. R., Borre, Y., O'Brien, C., Patterson, E., El Aidy, S., Deane, J., et al. (2016). Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr. Res. 82, 109-118. doi: 10.1016/j.jpsychires.2016.07.019
89. Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., et al. (2015). Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30, 1351-1360. doi: 10.1002/mds.26307
90. Khosravi, A., Yáñez, A., Price, J. G., Chow, A., Merad, M., Goodridge, H. S., et al. (2014). Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 15, 374-381. doi: 10.1016/j.chom.2014.02.006
91. Kim, S. H., and Lord, C. (2012). New autism diagnostic interview-revised algorithms for toddlers and young preschoolers from 12 to 47 months of age. J. Autism Dev. Disord. 42, 82-93. doi: 10.1007/s10803-011-1213-1
92. Koba, K., Akahoshi, A., Yamasaki, M., Tanaka, K., Yamada, K., Iwata, T., et al. (2002). Dietary conjugated linolenic acid in relation to CLA differently modifies body fat mass and serum and liver lipid levels in rats. Lipids 37, 343-350. doi: 10.1007/s11745-002-0901-7
93. Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., et al. (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585. doi: 10.1038/nm.3145
94. Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., et al. (2017). Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 17:120. doi: 10.1186/s12866-017-1027-1
95. Konturek, P. C., Koziel, J., Dieterich, W., Haziri, S., Wirtz, I., Glowczyk, K., et al. (2016). Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. J. Physiol. Pharmacol. 67, 859-866
96. Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y. C., Braun, J., et al. (2002). Selected loss of tolerance evidenced by Crohns disease-associated immune responses to auto-and microbial antigens. Gastroenterology 123, 689-699. doi: 10.1053/gast.2002.35379
97. Laparra, J. M., Olivares, M., Gallina, O., and Sanz, Y. (2012). Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7:e30744. doi: 10.1371/journal.pone.0030744
98. Larrosa, M., González-Sarrías, A., García-Conesa, M. T., Tomás-Barberán, F. A., and Espín, J. C. (2006). Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J. Agric. Food Chem. 54, 1611-1620. doi: 10.1021/jf0527403
99. Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín-Ortuño, M., Toti, S., et al. (2010). Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem. 21, 717-725. doi: 10.1016/j.jnutbio.2009.04.012
100. Lawley, T. D., and Walker, A. W. (2013). Intestinal colonization resistance. Immunology 138, 1-11. doi: 10.1111/j.1365-2567.2012.03616.x
101. LeBlanc, J. G., Laiño, J. E., del Valle, M. J., Vannini, V., Van Sinderen, D., Taranto, M. P., etal. (2011). B-Group vitamin production by lactic acid bacteria-current knowledge and potential applications. J. Appl. Microbiol. 111, 1297-1309. doi: 10.1111/j.1365-2672.2011.05157.x
102. Lee, H. C., Jenner, A. M., Low, C. S., and Lee, Y. K. (2006). Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 157, 876-884. doi: 10.1016/j.resmic.2006.07.004
103. Lee, H. Y., Park, J.-H., Seok, S.-H., Baek, M.-W., Kim, D.-J., Lee, K.-E., et al. (2006). Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim. Biophys. Acta 1761, 736-744. doi: 10.1016/j.bbalip.2006.05.007
104. Lee, J. M., Wagner, M., Xiao, R., Kim, K. H., Feng, D., Lazar, M. A., et al. (2014). Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516, 112-115. doi: 10.1038/nature13961
105. Lee, J. W., Kim, E. H., Yim, I. B., and Joo, H. G. (2004). Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci. 5, 41-48
106. Lennard-Jones, J. E. (1989). Classification of inflammatory bowel disease. Scand. J. Gastroenterol. 24, 2-6. doi: 10.3109/00365528909091339
107. Lepage, P., Colombet, J., Marteau, P., Sime-Ngando, T., Doré, J., and Leclerc, M. (2008). Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 57, 424-425. doi: 10.1136/gut.2007.134668
108. Lerner, A., Aminov, R., and Matthias, T. (2016). Dysbiosis may trigger autoimmune diseases via inappropriate post-translational modification of host proteins. Front. Microbiol. 7:84. doi: 10.3389/fmicb.2016.00084
109. Lerner, A., and Matthias, T. (2015). Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 14, 479-489. doi: 10.1016/j.autrev.2015.01.009
110. Lerner, A., Aminov, R., and Matthias, T. (2017a). Transglutaminases in dysbiosis as potential environmental drivers of autoimmunity. Front. Microbiol. 8:66. doi: 10.3389/fmicb.2017.00066
111. Lerner, A., Neidhöfer, S., and Matthias, T. (2017b). The gut microbiome feelings of the brain: a perspective for non-microbiologists. Microorganisms 5:E66. doi: 10.3390/microorganisms5040066
112. Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., et al. (2015). Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825-834. doi: 10.1056/NEJMoa1408913
113. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075. doi: 10.1073/pnas.0504978102
114. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023. doi: 10.1038/4441022a
115. Li, Y., Kundu, P., Seow, S. W., de Matos, C. T., Aronsson, L., Chin, K. C., et al. (2012). Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC Min/+ mice. Carcinogenesis 33, 1231-1238. doi: 10.1093/carcin/bgs137
116. Lindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venäläinen, J., Mäki, M., et al. (2008). Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin. Exp. Immunol. 152, 552-558. doi: 10.1111/j.1365-2249.2008.03635.x
117. Liu, X., Zou, Q., Zeng, B., Fang, Y., and Wei, H. (2013). Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr. Microbiol. 67, 170-176. doi: 10.1007/s00284-013-0338-1
118. Lloyd-Price, J., Abu-Ali, G., and Huttenhower, C. (2016). The healthy human microbiome. Genome Med. 8:51. doi: 10.1186/s13073-016-0307-y
119. Loftus, E. V. (2004). Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517. doi: 10.1053/j.gastro.2004.01.063
120. Ludvigsson, J. F., Montgomery, S. M., Ekbom, A., Brandt, L., and Granath, F. (2009). Small-intestinal histopathology and mortality risk in celiac disease. JAMA 302, 1171-1178. doi: 10.1001/jama.2009.1320
121. Luo, X. M., Edwards, M. R., Mu, Q., Yu, Y., Vieson, M. D., Reilly, C. M., et al. (2018). Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl. Environ. Microbiol. 84:e2288-17. doi: 10.1128/AEM.02288-17
122. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., et al. (2014). A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283. doi: 10.1136/gutjnl-2013-304833
123. Mahe, S., Corthier, G., and Dubos, F. (1987). Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice. Infect. Immun. 55, 1801-1805
124. Marasco, G., Di Biase, A. R., Schiumerini, R., Eusebi, L. H., Iughetti, L., Ravaioli, F., et al. (2016). Gut microbiota and celiac disease. Dig. Dis. Sci. 61, 1461-1472. doi: 10.1007/s10620-015-4020-2
125. McNally, L., and Brown, S. P. (2015). Building the microbiome in health and disease: niche construction and social conflict in bacteria. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370:20140298. doi: 10.1098/rstb.2014.0298
126. Medina, M., De Palma, G., Ribes-Koninckx, C., Calabuig, M., and Sanz, Y. (2008). Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J. Inflamm. 5:19. doi: 10.1186/1476-9255-5-19
127. Miernikiewicz, P., Klopot, A., Soluch, R., Szkuta, P., Kska, W., Hodyra-Stefaniak, K., et al. (2016). T4 phage tail adhesin gp12 counteracts LPS-induced inflammation in vivo. Front. Microbiol. 7:1112. doi: 10.3389/fmicb.2016.01112
128. Moncrief, J. S., Duncan, A. J., Wright, R. L., Barroso, L. A., and Wilkins, T. D. (1998). Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect. Immun. 66, 1735-1739
129. Mulder, S. J., and Mulder-Bos, G. C. (2006). Most probable origin of coeliac disease is low immune globulin A in the intestine caused by malfunction of Peyer's patches. Med. Hypotheses 66, 757-762. doi: 10.1016/j.mehy.2005.09.050
130. Murri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., et al. (2013). Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11:46. doi: 10.1186/1741-7015-11-46
131. Mustalahti, K., Catassi, C., Reunanen, A., Fabiani, E., Heier, M., McMillan, S., et al. (2010). The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann. Med. 42, 587-595. doi: 10.3109/07853890.2010.505931
132. Nadal, I., Donant, E., Ribes-Koninckx, C., Calabuig, M., and Sanz, Y. (2007). Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56, 1669-1674. doi: 10.1099/jmm.0.47410-0
133. Nagao-Kitamoto, H., Shreiner, A. B., Gilliland, M. G. I. I. I., Kitamoto, S., Ishii, C., Hirayama, A., et al. (2016). Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell. Mol. Gastroenterol. Hepatol. 2, 468-481
134. Neyrinck, A. M., Possemiers, S., Druart, C., Wiele, T. V. D., Backer, F. D., Cani, P. D., et al. (2011). Prebiotic effects of wheat arabinoxylan related to the increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 6:e20944. doi: 10.1371/journal.pone.0020944
135. Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012). Host-gut microbiota metabolic interactions. Science 336, 1262-1267. doi: 10.1126/science.1223813
136. Nie, Y. F., Hu, J., and Yan, X.-H. (2015). Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J. Zhejiang Univ. Sci. B 16, 436-446. doi: 10.1631/jzus.b1400327
137. Nishioku, T., Matsumoto, J., Dohgu, S., Sumi, N., Miyao, K., Takata, F., et al. (2010). Tumor necrosis factor-a mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J. Pharmacol. Sci. 112, 251-254. doi: 10.1254/jphs.09292sc
138. Ochoa-Cortes, F., Turco, F., Linan-Rico, A., Soghomonyan, S., Whitaker, E., Wehner, S., et al. (2015). Enteric glial cells: a new frontier in neurogastroenterology and clinical target for inflammatory bowel diseases. Inflamm. Bowel Dis. 22, 433-449. doi: 10.1097/MIB.0000000000000667
139. Okunishi, K., Dohi, M., Nakagome, K., Tanaka, R., Mizuno, S., Matsumoto, K., et al. (2005). A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175, 4745-4753. doi: 10.4049/jimmunol.175.7.4745
140. Olivares, M., Castillejo, G., Varea, V., and Sanz, Y. (2014). Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br. J. Nutr. 112, 30-40. doi: 10.1017/S0007114514000609
141. Orberg, E. T., Fan, H., Tam, A. J., Dejea, C. M., Shields, C. D., Wu, S., et al. (2017). The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol. 10, 421-433. doi: 10.1038/mi.2016.53
142. Patrick, S., Jobling, K. L., O'Connor, D., Thacker, Z., Dryden, D. T., and Blakely, G. W. (2011). A unique homologue of the eukaryotic protein-modifier ubiquitin present in the bacterium Bacteroides fragilis, a predominant resident of the human gastrointestinal tract. Microbiology 157, 3071-3078. doi: 10.1099/mic.0.049940-0
143. Paust, S., Lu, L., Mccarty, N., and Cantor, H. (2004). Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 101, 10398-10403. doi: 10.1073/pnas.0403342101
144. Payne, A. N., Chassard, C., Banz, Y., and Lacroix, C. (2012). The composition and metabolic activity of child gut microbiota demonstrate differential adaptation to varied nutrient loads in an in vitro model of colonic fermentation. FEMS Microbiol. Ecol. 80, 608-623. doi: 10.1111/j.1574-6941.2012.01330.x
145. Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N., and Galgiani, J. N. (1994). Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann. Intern. Med. 120, 272-277. doi: 10.7326/0003-4819-120-4-199402150-00003
146. Peng, L., He, Z., Chen, W., Holzman, I. R., and Lin, J. (2007). Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37-41. doi: 10.1203/01.pdr.0000250014.92242.f3
147. Pépin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., et al. (2005). Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 41, 1254-1260. doi: 10.1086/496986
148. Perez-Cano, F. J., Gonzalez-Castro, A., Castellote, C., Franch, A., and Castell, M. (2010). Influence of breast milk polyamines on suckling rat immune system maturation. Dev. Comp. Immunol. 34, 210-218. doi: 10.1016/j.dci.2009.10.001
149. Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., and Battino, M. (2016). Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74, 624-634. doi: 10.1093/nutrit/nuw023
150. Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., Mcsweeney, C. S., Sly, L. I., et al. (2010). Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420-2428. doi: 10.1038/ajg.2010.281
151. Pool-Zobel, B. L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C., et al. (1996). Lactobacillus-and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 26, 365-380. doi: 10.1080/01635589609514492
152. Pruitt, R. N., Chumbler, N. M., Rutherford, S. A., Farrow, M. A., Friedman, D. B., Spiller, B., et al. (2012). Structural determinants of Clostridium difficile toxin a glucosyltransferase activity. J. Biol. Chem. 287, 8013-8020. doi: 10.1074/jbc. M111.298414
153. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60. doi: 10.1038/nature11450
154. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241. doi: 10.1016/j.cell.2004.07.002
155. Rooks, M. G., and Garrett, W. S. (2016). Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341-352. doi: 10.1038/nri.2016.42
156. Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., and Han, Y. W. (2013). Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206. doi: 10.1016/j.chom.2013.07.012
157. Ruseler-van Embden, J. G. H., and Both-Patoir, H. C. (1983). Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek 49, 125-132. doi: 10.1007/BF00393670
158. Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., et al. (1998). Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80, 147-171. doi: 10.1079/bjn19980108
159. Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., et al. (2010). Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11, 76-83. doi: 10.1038/ni.1825
160. Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., et al. (2008). Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U.S.A. 105, 16767-16772. doi: 10.1073/pnas.0808567105
161. Samuel, P., Holtzman, C. M., Meilman, E., and Sekowski, I. (1973). Effect of neomycin and other antibiotics on serum cholesterol levels and on 7a-dehydroxylation of bile acids by the fecal bacterial flora in man. Circ. Res. 33, 393-402. doi: 10.1161/01.res.33.4.393
162. Sanz, Y., Palma, G. D., and Laparra, M. (2011). Unraveling the ties between celiac disease and intestinal microbiota. Int. Rev. Immunol. 30, 207-218. doi: 10.3109/08830185.2011.599084
163. Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., et al. (2014). Gut dysbiosis and detection of 'live gut bacteria' in blood of Japanese patients with type 2 diabetes. Diabetes Care 37, 2343-2350. doi: 10.2337/dc13-2817
164. Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., et al. (2013). Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2:e01202. doi: 10.7554/eLife.01202
165. Selma, M. V., Espin, J. C., and Tomas-Barberan, F. A. (2009). Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 57, 6485-6501. doi: 10.1021/jf902107d
166. Sender, R., Fuchs, S., and Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14:e1002533. doi: 10.1371/journal.pbio.1002533
167. Shi, L., Zhang, Z., Angela, M. Y., Wang, W., Wei, Z., Akhter, E., et al. (2014). The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One 9:e93846. doi: 10.1371/journal.pone.0093846
168. Shultz, S. R., Aziz, N. A., Yang, L., Sun, M., Macfabe, D. F., and O'Brien, T. J. (2015). Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats. Behav. Brain Res. 278, 542-548. doi: 10.1016/j.bbr.2014.10.050
169. Silva, A. M., Bambirra, E. A., Oliveira, A. L., Souza, P. P., Gomes, D. A., Vieira, E. C., et al. (1999). Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice. J. Appl. Microbiol. 86, 331-336. doi: 10.1046/j.1365-2672.1999.00674.x
170. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., and Reddy, B. S. (1997). Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841. doi: 10.1093/carcin/18.4.833
171. Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089. doi: 10.1126/science.aac4255
172. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi: 10.1073/pnas.0804812105
173. Solinas, G., Summermatter, S., Mainieri, D., Gubler, M., Montani, J. P., Seydoux, J., et al. (2006). Corticotropin-releasing hormone directly stimulates thermogenesis in skeletal muscle possibly through substrate cycling between de novo lipogenesis and lipid oxidation. Endocrinology 147, 31-38. doi: 10.1210/en.2005-1033
174. Song, H. J., Shim, K.-N., Jung, S.-A., Choi, H. J., Lee, M. A., Ryu, K. H., et al. (2008). Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile. Korean J. Intern. Med. 23, 9-15. doi: 10.3904/kjim.2008.23.1.9
175. Song, Y., Liu, C., and Finegold, S. M. (2004). Real-time PCR quantitation of Clostridia in feces of autistic children. Appl. Environ. Microbiol. 70, 6459-6465. doi: 10.1128/aem.70.11.6459-6465.2004
176. Soret, R., Chevalier, J., De Coppet, P., Poupeau, G., Derkinderen, P., Segain, J. P., et al. (2010). Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138, 1772-1782. doi: 10.1053/j.gastro.2010.01.053
177. Sorg, J. A., and Sonenshein, A. L. (2008). Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190, 2505-2512. doi: 10.1128/jb.01765-07
178. Staels, B., and Fonseca, V. A. (2009). Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 32(Suppl. 2), S237-S245. doi: 10.2337/dc09-s355
179. Stedtfeld, R. D., Chai, B., Crawford, R. B., Stedtfeld, T. M., Williams, M. R., Xiangwen, S., et al. (2017). Modulatory influence of segmented filamentous bacteria on transcriptomic response of gnotobiotic mice exposed to TCDD. Front. Microbiol. 8:1708. doi: 10.3389/fmicb.2017.01708
180. Stene, L. C., Honeyman, M. C., Hoffenberg, E. J., Haas, J. E., Sokol, R. J., Emery, L., et al. (2006). Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 101, 2333-2340. doi: 10.1111/j.1572-0241.2006.00741.x
181. Stepniak, D., and Koning, F. (2006). Celiac disease-sandwiched between innate and adaptive immunity. Hum. Immunol. 67, 460-468. doi: 10.1016/j.humimm.2006.03.011
182. Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., et al. (2007). Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 56, 343-350. doi: 10.1136/gut.2006.098160
183. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., et al. (2009). Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584. doi: 10.1111/j.1462-2920.2009.01982.x
184. Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., et al. (2009). GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-2832. doi: 10.1158/0008-5472.CAN-08-4466
185. The Human Microbiome Project Consortium. (2012). A framework for human microbiome research. Nature 486, 215-221. doi: 10.1038/nature11209
186. Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., et al. (2014). Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5:3114. doi: 10.1038/ncomms4114
187. Tjellström, B., Stenhammar, L., Högberg, L., Fälth-Magnusson, K., Magnusson, K. E., Midtvedt, T., et al. (2005). Gut microflora associated characteristics in children with celiac disease. Am. J. Gastroenterol. 100, 2784-2788. doi: 10.1111/j.1572-0241.2005.00313.x
188. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., et al. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes Metab. Res. Rev. 61, 364-371. doi: 10.2337/db11-1019
189. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009a). A core gut microbiome in obese and lean twins. Nature 457, 480-484. doi: 10.1038/nature07540
190. Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., and Gordon, J. I. (2009b). The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1:6ra14. doi: 10.1126/scitranslmed.3000322
191. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031. doi: 10.1038/nature05414
192. Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., et al. (2006). A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12, 782-786. doi: 10.1111/j.1469-0691.2006.01494.x
193. Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R., and Vaneechoutte, M. (2017). Pro-and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci. Rep. 7:8004. doi: 10.1038/s41598-017-08336-9
194. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., De Vos, W. M. D., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415. doi: 10.1056/nejmoa1205037
195. Vasiliauskas, E. A., Kam, L. Y., Karp, L. C., Gaiennie, J., Yang, H., and Targan, S. R. (2000). Marker antibody expression stratifies Crohns disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47, 487-496. doi: 10.1136/gut.47.4.487
196. Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., et al. (2013). Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83, 308-315. doi: 10.1038/ki.2012.345
197. Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A. P., et al. (2014). Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41, 296-310. doi: 10.1016/j.immuni.2014.06.014
198. Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084. doi: 10.1126/science.aad1329
199. Wagner, J., Maksimovic, J., Farries, G., Sim, W. H., Bishop, R. F., Cameron, D. J., et al. (2013). Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm. Bowel Dis. 19, 1598-1608. doi: 10.1097/MIB.0b013e318292477c
200. Wang, L. W., Tancredi, D. J., and Thomas, D. W. (2011). The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J. Dev. Behav. Pediatr. 32, 351-360. doi: 10.1097/dbp.0b013e31821bd06a
201. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., et al. (2012). Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320-329. doi: 10.1038/ismej.2011.109
202. Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63. doi: 10.1038/nature09922
203. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., et al. (2005). Reduced paneth cell a-defensins in ileal Crohns disease. Proc. Natl. Acad. Sci. U.S.A. 102, 18129-18134. doi: 10.1073/pnas.0505256102
204. Wei, W., Sun, W., Yu, S., Yang, Y., and Ai, L. (2016). Butyrate production from high-fiber diet protects against lymphoma tumor. Leuk. Lymphoma 57, 2401-2408. doi: 10.3109/10428194.2016.1144879
205. Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., et al. (1999). Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J. Am. Coll. Cardiol. 34, 1975-1981. doi: 10.1016/S0735-1097(99)00448-9
206. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703. doi: 10.1073/pnas.0812874106
207. Willing, B. P., Dicksved, J., Halfvarson, J., Andersson, A. F., Lucio, M., Zheng, Z., et al. (2010). A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844.e1-1854.e1. doi: 10.1053/j.gastro.2010.08.049
208. Wollowski, I., Ji, S. T., Bakalinsky, A. T., Neudecker, C., and Pool-Zobel, B. L. (1999). Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J. Nutr. 129, 77-82. doi: 10.1093/jn/129.1.77
209. World Health Organization [WHO] (2016). Obesity and Overweight. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/[accessed 1 Jul. 2017]
210. World Health Organization [WHO] (2017). Autism Spectrum Disorders. Available at: http://www.who.int/mediacentre/factsheets/autism-spectrum-disorders/en/[accessed 1 Jul. 2017]
211. Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., et al. (2013). Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66, 462-470. doi: 10.1007/s00248-013-0245-9
212. Wu, S., Lim, K. C., Huang, J., Saidi, R. F., and Sears, C. L. (1998). Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. U.S.A. 95, 14979-14984. doi: 10.1073/pnas.95.25.14979
213. Wu, S., Morin, P. J., Maouyo, D., and Sears, C. L. (2003). Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124, 392-400. doi: 10.1053/gast.2003.50047
214. Wu, S., Rhee, K. J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H. R., et al. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022. doi: 10.1038/nm.2015
215. Wu, Y., Wu, J., Chen, T., Li, Q., Peng, W., Li, H., et al. (2018). Fusobacterium nucleatum potentiates intestinal tumorigenesis in mice via a toll-like receptor 4/p21-activated kinase 1 cascade. Dig. Dis. Sci. 63, 1210-1218. doi: 10.1007/s10620-018-4999-2
216. Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., et al. (2004). Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U.S.A. 101, 1045-1050. doi: 10.1073/pnas.2637002100
217. Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., et al. (2015). Gut dysbiosis is linked to hypertension. Hypertension 65, 1331-1340. doi: 10.1161/HYPERTENSIONAHA.115.05315
218. Yiu, J. H., Dorweiler, B., and Woo, C. W. (2017). Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J. Mol. Med. 95, 13-20. doi: 10.1007/s00109-016-1474-4
219. Yui, K., Kawasaki, Y., Yamada, H., and Ogawa, S. (2016). Oxidative stress and nitric oxide in autism spectrum disorder and other neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 15, 587-596. doi: 10.2174/1871527315666160413121751